CSNpharm

CSNpharm logo

Csnpharm is committed to providing you with high quality products and outstanding services. We supply over 5000 bioactive compounds in stock, including inhibitors, agonists and natural products for laboratory and scientific use. Csnpharm has always been committed to develop quality products that are validated by NMR, UPLC, LC-MS, GC, Chiral HPLC and so on. We have a professional technical support team for customer service with years of experience in life science. Csnpharm is your reliable partner for scientific research.

Company Website

Product Listing

SB-590885 1mg  | ≥98%

CSNpharm

SB-590885 is a potent B-Raf inhibitor with Ki of 0.16 nM, 11-fold greater selectivity for B-Raf over c-Raf, no inhibition to other human kinases.

More Information Supplier Page

SBC-115076 50mg  | ≥99%

CSNpharm

SBC-115076 is an anti-proprotein convertase subtilisin kexin type 9 (anti-PCSK9) compounds, for the treatment and/or prevention of cardiovascular diseases.

More Information Supplier Page

SBC-115076 5mg  | ≥99%

CSNpharm

SBC-115076 is an anti-proprotein convertase subtilisin kexin type 9 (anti-PCSK9) compounds, for the treatment and/or prevention of cardiovascular diseases.

More Information Supplier Page

SBC-115076 1mg  | ≥99%

CSNpharm

SBC-115076 is an anti-proprotein convertase subtilisin kexin type 9 (anti-PCSK9) compounds, for the treatment and/or prevention of cardiovascular diseases.

More Information Supplier Page

SBC-115076 100mg  | ≥99%

CSNpharm

SBC-115076 is an anti-proprotein convertase subtilisin kexin type 9 (anti-PCSK9) compounds, for the treatment and/or prevention of cardiovascular diseases.

More Information Supplier Page

SBC-115076 25mg  | ≥99%

CSNpharm

SBC-115076 is an anti-proprotein convertase subtilisin kexin type 9 (anti-PCSK9) compounds, for the treatment and/or prevention of cardiovascular diseases.

More Information Supplier Page

SBC-115076 10mg  | ≥99%

CSNpharm

SBC-115076 is an anti-proprotein convertase subtilisin kexin type 9 (anti-PCSK9) compounds, for the treatment and/or prevention of cardiovascular diseases.

More Information Supplier Page

SBE-β-CD 1g  | ≥99%

CSNpharm

SBE-β-CD, a modified cyclodextrin, is designed to optimize the solubility, stability, bioavailability and dosing of drugs.

More Information Supplier Page

SBE-β-CD 5g  | ≥99%

CSNpharm

SBE-β-CD, a modified cyclodextrin, is designed to optimize the solubility, stability, bioavailability and dosing of drugs.

More Information Supplier Page

SC 236 100mg  | ≥99%

CSNpharm

SC-236 is an orally active inhibitor of COX-2. SC-236 displays anti-inflammatory properties and potent antimetastatic activity against both experimental metastases and spontaneous metastases arising following primary tumor excision.

More Information Supplier Page

SC 236 10mg  | ≥99%

CSNpharm

SC-236 is an orally active inhibitor of COX-2. SC-236 displays anti-inflammatory properties and potent antimetastatic activity against both experimental metastases and spontaneous metastases arising following primary tumor excision.

More Information Supplier Page

SC 236 5mg  | ≥99%

CSNpharm

SC-236 is an orally active inhibitor of COX-2. SC-236 displays anti-inflammatory properties and potent antimetastatic activity against both experimental metastases and spontaneous metastases arising following primary tumor excision.

More Information Supplier Page

SC 236 50mg  | ≥99%

CSNpharm

SC-236 is an orally active inhibitor of COX-2. SC-236 displays anti-inflammatory properties and potent antimetastatic activity against both experimental metastases and spontaneous metastases arising following primary tumor excision.

More Information Supplier Page

SC-560 50mg  | ≥99%

CSNpharm

SC-560 is a highly selective cyclooxygenase-1 (COX-1) inhibitor (IC50 values are 0.009 and 6.3 μM for COX-1 and COX-2 respectively). It inhibits COX-1-derived platelet thromboxane B2, gastric PGE2 and dermal PDE2 production and significantly reduces ovarian surface epithelial tumor growth in vivo.

More Information Supplier Page

SC-560 5mg  | ≥99%

CSNpharm

SC-560 is a highly selective cyclooxygenase-1 (COX-1) inhibitor (IC50 values are 0.009 and 6.3 μM for COX-1 and COX-2 respectively). It inhibits COX-1-derived platelet thromboxane B2, gastric PGE2 and dermal PDE2 production and significantly reduces ovarian surface epithelial tumor growth in vivo.

More Information Supplier Page

SC-560 10mg  | ≥99%

CSNpharm

SC-560 is a highly selective cyclooxygenase-1 (COX-1) inhibitor (IC50 values are 0.009 and 6.3 μM for COX-1 and COX-2 respectively). It inhibits COX-1-derived platelet thromboxane B2, gastric PGE2 and dermal PDE2 production and significantly reduces ovarian surface epithelial tumor growth in vivo.

More Information Supplier Page

SC-560 100mg  | ≥99%

CSNpharm

SC-560 is a highly selective cyclooxygenase-1 (COX-1) inhibitor (IC50 values are 0.009 and 6.3 μM for COX-1 and COX-2 respectively). It inhibits COX-1-derived platelet thromboxane B2, gastric PGE2 and dermal PDE2 production and significantly reduces ovarian surface epithelial tumor growth in vivo.

More Information Supplier Page

SC-560 25mg  | ≥99%

CSNpharm

SC-560 is a highly selective cyclooxygenase-1 (COX-1) inhibitor (IC50 values are 0.009 and 6.3 μM for COX-1 and COX-2 respectively). It inhibits COX-1-derived platelet thromboxane B2, gastric PGE2 and dermal PDE2 production and significantly reduces ovarian surface epithelial tumor growth in vivo.

More Information Supplier Page

SC-560 1mg  | ≥99%

CSNpharm

SC-560 is a highly selective cyclooxygenase-1 (COX-1) inhibitor (IC50 values are 0.009 and 6.3 μM for COX-1 and COX-2 respectively). It inhibits COX-1-derived platelet thromboxane B2, gastric PGE2 and dermal PDE2 production and significantly reduces ovarian surface epithelial tumor growth in vivo.

More Information Supplier Page

SC514 5mg  | ≥99%

CSNpharm

SC514 is a potent, reversible, ATP-competitive and highly selective IKK-β(IKK-2) inhibitor with IC50 value ranging in 3-12 µM.

More Information Supplier Page

SC514 50mg  | ≥99%

CSNpharm

SC514 is a potent, reversible, ATP-competitive and highly selective IKK-β(IKK-2) inhibitor with IC50 value ranging in 3-12 µM.

More Information Supplier Page

SC514 10mg  | ≥99%

CSNpharm

SC514 is a potent, reversible, ATP-competitive and highly selective IKK-β(IKK-2) inhibitor with IC50 value ranging in 3-12 µM.

More Information Supplier Page

SC66 100mg  | ≥99%

CSNpharm

SC66 is an allosteric and dual-inhibitory-function inhibitor of Akt which can lead to a reduction in total and phospho-AKT levels.

More Information Supplier Page

SC66 10mg  | ≥99%

CSNpharm

SC66 is an allosteric and dual-inhibitory-function inhibitor of Akt which can lead to a reduction in total and phospho-AKT levels.

More Information Supplier Page

SC66 5mg  | ≥99%

CSNpharm

SC66 is an allosteric and dual-inhibitory-function inhibitor of Akt which can lead to a reduction in total and phospho-AKT levels.

More Information Supplier Page

SC66 50mg  | ≥99%

CSNpharm

SC66 is an allosteric and dual-inhibitory-function inhibitor of Akt which can lead to a reduction in total and phospho-AKT levels.

More Information Supplier Page

SC66 25mg  | ≥99%

CSNpharm

SC66 is an allosteric and dual-inhibitory-function inhibitor of Akt which can lead to a reduction in total and phospho-AKT levels.

More Information Supplier Page